Mixed Bacteriophage MS2-L2 VLPs Elicit Long-Lasting Protective Antibodies against HPV Pseudovirus 51
Three prophylactic vaccines are approved to protect against HPV infections. These vaccines are highly immunogenic. The most recent HPV vaccine, Gardasil-9, protects against HPV types associated with ~90% of cervical cancer (worldwide). Thus, ~10% of HPV-associated cancers are not protected by Gardas...
Main Authors: | Rashi Yadav, Lukai Zhai, Nitesh K. Kunda, Pavan Muttil, Ebenezer Tumban |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/13/6/1113 |
Similar Items
-
Evaluation of the thermal stability and the protective efficacy of spray-dried HPV vaccine, Gardasil® 9
by: Nitesh K. Kunda, et al.
Published: (2019-08-01) -
Potential Applications of Thermophilic Bacteriophages in One Health
by: Hong Liu, et al.
Published: (2023-05-01) -
A Comparative Study on Delivery of Externally Attached DNA by Papillomavirus VLPs and Pseudoviruses
by: Sarah Brendle, et al.
Published: (2021-12-01) -
Molecular characterization of the PhiKo endolysin from Thermus thermophilus HB27 bacteriophage phiKo and its cryptic lytic peptide RAP-29
by: Monika Szadkowska, et al.
Published: (2024-01-01) -
Cloning and Characterization of a Thermostable Endolysin of Bacteriophage TP-84 as a Potential Disinfectant and Biofilm-Removing Biological Agent
by: Joanna Żebrowska, et al.
Published: (2022-07-01)